SCHEMBL6415056

SCHEMBL6415056

O=C1SC(CN2CCC(Cc3cc(F)ccc3Cl)CC2)CN1c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.35
GMNN O75496 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
BLM P54132 1/20 0.35
GRIN2B Q13224 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CNR1 P21554 2/20 0.34
SLC6A4 P31645 2/20 0.34
CCR3 P51677 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
CCR5 P51681 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6417606 0.92 P2RX7 (0.41) SLC6A4CCR3MEN1KMT2AP2RX7
SCHEMBL6416434 0.92 MEN1 (0.41) CNR1SLC6A4CCR3MEN1POLB
SCHEMBL6409743 0.91 SLC6A4 (0.41) GRIN1GMNNTP53CYP3A4ALOX15
SCHEMBL6413561 0.90 HTR1A (0.44) TP53SLC6A4CCR3CCR5P2RX7
SCHEMBL6416360 0.86 SLC6A4 (0.40) SLC6A4CCR3MEN1POLBKMT2A
SCHEMBL6413317 0.86 HTR1A (0.50) SLC6A4CCR3MEN1POLBKMT2A
SCHEMBL6411958 0.84 HTR1A (0.41) TP53CNR1SLC6A4HTR1A
SCHEMBL6412140 0.84 HTR1A (0.46) SLC6A4CCR3MEN1POLBKMT2A
SCHEMBL6417247 0.84 HTR1A (0.41) CNR1SLC6A4CCR3DRD2HTR1A
SCHEMBL6413207 0.83 CCR3 (0.37) SLC6A4CCR3CCR5DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065140-A1 Serotonine reuptake inhibitor SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2005-03-24 US disclosed
EP-1466901-A1 SEROTONINE REUPTAKE INHIBITOR SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065140-A1 Serotonine reuptake inhibitor HTR1A, SLC6A4, SLC6A2 GRIN1 56/4885GMNN 2225/4885TP53 4760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.